4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Vor Biopharma Inc. (VOR) operates in the Biotechnology industry and is headquartered in Boston, United States with about 76 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, VOR reported $0M in revenue and ($696M) in net income.
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($372M) | ($121M) | ($126M) | ($93M) | — |
| Net Income | ($696M) | ($117M) | ($118M) | ($92M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($35M) | ($36M) | ($28M) | ($274M) | ($33M) |
| Net Income | ($220M) | $1.7B | ($813M) | ($1.6B) | ($32M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $464M | $143M | $198M | $299M | — |
| Total Liabilities | $628M | $46M | $47M | $49M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VOR viewer.
About TickerBase · Data methodology & sources